News Australia's CSL makes $11.7bn bid for Swiss pharma Vifor Australian biotech group CSL has agreed a deal to acquire Swiss drugmaker Vifor Pharma in an all-cash deal that expands its speciality medicines business.
News Vifor forges iron drug partnership with Fresenius in China Vifor Pharma has forged a strategic partnership with Fresenius Kabi, focusing on marketing a portfolio of iron deficiency drugs.
News Shield Therapeutics soars on FDA approval of iron deficiency... Shares in Shield Therapeutics were soaring this morning after the FDA granted a broader than expected label for its iron deficiency drug.
News UK project addresses capacity issue in CGT manufacturing A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face